Regorafenib 40 Mg (Generic)

What is Regorafenib 40 Mg?

Regorafenib 40 Mg is a prescription medication primarily used in oncology for the treatment of certain types of cancer. It contains the active ingredient Regorafenib, which belongs to a class of drugs called kinase inhibitors. These agents work by blocking specific enzymes involved in tumor growth and the development of blood vessels that supply cancer cells.

Manufactured by Natco Pharma Ltd., Regorafenib 40 Mg is often prescribed to patients diagnosed with cancer of the colon and rectum. This medication helps to slow down the progression of the disease by targeting the underlying molecular pathways responsible for cancer cell proliferation and angiogenesis.

Designed to be taken orally, Regorafenib 40 Mg offers an important option for patients requiring targeted therapy. It is typically used when conventional chemotherapy has not been sufficiently effective or when the cancer has advanced despite other treatments.

This medicine is widely used in Malaysia and other countries under medical supervision, providing cancer patients with a modern therapy that complements other treatment modalities. Its mechanism and effectiveness depend on strict adherence to the prescribed dosage and medical guidance.

Uses of Regorafenib 40 Mg

• Treatment of metastatic colorectal cancer
• Management of advanced colon and rectum cancer after failure of prior chemotherapy
• Targeted therapy for patients with cancer resistant to traditional treatment options

How Regorafenib 40 Mg Works

Regorafenib 40 Mg works by inhibiting multiple protein kinases that contribute to cancer growth and angiogenesis. Specifically, it blocks the activity of enzymes involved in cell signalling pathways that promote tumor cell proliferation and the formation of new blood vessels that supply tumors. By disrupting these processes, Regorafenib effectively inhibits tumor progression and may lead to tumor shrinkage or controlled growth.

The drug targets kinases such as VEGFR, PDGFR, and RAF, which play crucial roles in cancer cell survival and the tumor microenvironment. This multi-kinase inhibition makes Regorafenib a valuable treatment option for colon and rectum cancers that are not responding to conventional therapies.

How to take Regorafenib 40 Mg

Regorafenib 40 Mg should be taken exactly as prescribed by your healthcare provider. It is an oral medication and should be taken with a low-fat meal to improve absorption. Avoid grapefruit or grapefruit juice while on this medication, as it can interfere with drug metabolism.

Swallow the tablet whole with water and do not crush or chew it. The usual dosing schedule includes a cycle of 3 weeks of treatment followed by 1 week off to allow the body to recover. Always follow the dosing instructions carefully and report any side effects to your doctor promptly.

Benefits of Regorafenib 40 Mg

• Targets multiple cancer growth pathways
• Oral administration offers convenience
• Useful for colorectal cancer resistant to other treatments
• Slows tumor progression and growth
• Improves patient outcomes as part of comprehensive cancer management

Dosage and Administration

The recommended dose of Regorafenib 40 Mg for adults with metastatic colorectal cancer is typically 160 mg taken once daily for 21 days followed by 7 days off treatment, comprising a 28-day cycle. Treatment duration depends on patient tolerance and therapeutic response.

Dosing adjustments may be necessary in cases of toxicity or adverse reactions, and any changes should be made under medical supervision. Patients should not alter their dose without consulting their healthcare provider.

Who Should Use Regorafenib 40 Mg?

Regorafenib 40 Mg is intended for adults diagnosed with metastatic colorectal cancer who have experienced progression after standard chemotherapy treatments. It is suitable for patients whose condition requires targeted multi-kinase inhibitor therapy and who are under oncologist supervision.

Who Should Avoid Regorafenib 40 Mg?

Patients with a history of severe allergic reactions to Regorafenib or any of its components should not use this medication. It is also contraindicated in individuals with uncontrolled hypertension, severe liver impairment, or active bleeding disorders.

Pregnant or breastfeeding women should avoid Regorafenib due to potential risks to the fetus or infant. Always inform your doctor of any existing health conditions before starting therapy.

Side Effects of Regorafenib 40 Mg

• Fatigue
• Hand-foot skin reaction (redness, pain, swelling of hands or feet)
• Diarrhea
• Nausea
• Loss of appetite
• Mouth sores
• High blood pressure
• Skin rash
• Hair thinning or loss
• Abdominal pain
• Weight loss
• Liver function abnormalities

Safety Advice

• Take Regorafenib exactly as directed by your healthcare provider
• Report any unusual bleeding, bruising, or severe side effects immediately
• Monitor blood pressure regularly during treatment
• Avoid grapefruit and grapefruit juice
• Inform your doctor about all other medications and supplements you are taking
• Use effective contraception during treatment and for a period after completion
• Do not drive or operate heavy machinery until you know how the medication affects you

Drug Interactions

• Drugs that affect liver enzymes CYP3A4, which may alter Regorafenib levels
• Blood thinners (anticoagulants) increasing bleeding risk
• Medications that may cause hypertension
• Other cancer therapies as advised by your oncologist

Storage Instructions

Store Regorafenib 40 Mg tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Do not use the medication past its expiration date. Proper storage helps maintain the effectiveness and safety of the product.

Where to buy Regorafenib 40 Mg in Malaysia?

Regorafenib 40 Mg is available through licensed pharmacies and authorized medical suppliers in Malaysia. It requires a doctor’s prescription due to its specialized use. Patients should purchase from reputable sources to ensure product authenticity and quality. Additionally, consultation with an oncologist is essential before starting therapy.

Frequently Asked Questions (FAQ)

What is the price of Regorafenib 40 Mg in Malaysia?

The price varies depending on the pharmacy and coverage. It is best to consult local pharmacies or your healthcare provider for the latest pricing information.

What happens if I miss a dose?

If you miss a dose, take it as soon as you remember on the same day. Do not double the dose the next day. Contact your doctor for guidance if you miss multiple doses.

Where can I find Regorafenib 40 Mg for sale?

Regorafenib 40 Mg can be purchased at licensed pharmacies in Malaysia with a valid prescription. Online pharmacies with proper accreditation may also supply it.

Is Regorafenib 40 Mg available in Malaysia?

Yes, Regorafenib 40 Mg is approved and available in Malaysia, primarily for the treatment of metastatic colorectal cancer under oncologist supervision.

Can I take Regorafenib 40 Mg with other medications?

Some medications may interact with Regorafenib. Always inform your doctor of all medicines and supplements you are taking to avoid harmful interactions.

How long does it take to see results from Regorafenib 40 Mg?

Response times vary. Some patients may notice improvements in tumor control after several weeks, but ongoing monitoring is necessary.

Are there any special precautions before starting Regorafenib 40 Mg?

Yes, informing your doctor about pre-existing conditions, allergies, and any current medications is essential to ensure safe use.

FAQs New for every times bellow faqs should only reference purpose

Conclusion

Regorafenib 40 Mg is an important targeted therapy option for patients with metastatic colorectal cancer, helping to inhibit tumor growth through multi-kinase blockade. Manufactured by Natco Pharma Ltd., this medication provides hope for managing colon and rectum cancers resistant to traditional treatments. Proper use under medical supervision, adherence to dosage, and monitoring for side effects are crucial for maximizing benefits safely. With availability in Malaysia, Regorafenib 40 Mg represents a valuable addition to modern oncology care.